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S-nitroso-N-acetylpenicillamine (SNAP) is a pharmacological agent with diverse biological effects that are mainly attributable to its
favorable characteristics as a nitric oxide (NO)-evolving agent. It is found that SNAP incorporates readily into dimyristoyl
phosphatidylcholine (DMPC) bilayer membranes; and an approximate penetration profile was obtained from the depth dependence of the
perturbation that it exerts on spin-labeled lipid chains. The profile of SNAP locates it deep in the hydrophobic core of both fluid- and gel-
phase membranes. The spin relaxation enhancement of spin-labeled phospholipids with nitroxide group located at different depths in DMPC
membranes was determined for nitric oxide (NO) and molecular oxygen (O2), at close to atomic spatial resolution. The relaxation
enhancement, which is proportional to the corresponding vertical membrane profile of the concentration-diffusion product, was measured in
the gel and fluid phases of the lipid bilayer. No significant membrane penetration was observed in the gel phase for the two water-dissolved
gases. In the fluid phase, the transmembrane profiles of NO and O2 are similar and could be well described by a sigmoidal function with a
maximum in the center of the bilayer, but that of NO is less steep and is shifted toward the center of the membrane, relative to that of O2.
These differences can be attributed mainly to the difference in hydrophobicity between the two gases and the presence of the donor in the NO
experiments. The biological implications of the above results are discussed.
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The diverse biological functions of nitric oxide (NO)
[1–6] keep it in the focus of biochemical research [7–
10]. Nitric oxide, like oxygen, is a hydrophobic gas,
hence biomembranes and other hydrophobic structures,
such as low-density lipoproteins or hydrophobic regions
of proteins, are potential sinks for NO and O2. Because of
the higher local concentrations and reduced possibility of
hydrolysis reactions, NO, O2, and their derived reactive0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2003.12.008
Abbreviations: CW, continuous wave; DMPC, 1,2-dimyristoyl-sn-
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nitric oxide; n-PCSL, 1-acyl-2-[n-(4,4-dimethyloxazolidine-N-oxyl)stea-
royl]-sn-glycero-3-phosphocholine; SNAP, S-nitroso-N-acetylpenicillamine
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phobic environments than in aqueous ones [11]. Indeed,
many functions that are assigned to NO are membrane-
associated [7], and at least one type of NO synthase
contains a myristoylation site and is largely associated
with (endothelial) cell membranes [12]. NO can inhibit
cytochrome c oxidase rapidly and reversibly, which may
be implicated in the cytotoxic effects of nitric oxide in the
nervous system and other tissues [13]. In the heart, NO
inhibits L-type Ca2 + channels but stimulates Ca2 + release
from the sarcoplasmic reticulum, and the cardiac Ca-
ATPase is also a membranous target of NO [9]. In human
erythrocytes, hemoglobin-derived S-nitrosothiol, generated
from imported NO, is associated predominantly with the
red blood cell membrane [14].
Nitric oxide also plays a role in lipid biochemistry. While
NO alone does not induce lipid peroxidation, it exhibits both
stimulation and inhibition of superoxide- and peroxynitrite-
dependent lipid peroxidation, depending on the ratio of the
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production of NO by donors such as S-nitroso-N-acetylpe-
nicillamine (SNAP) and S-nitrosoglutathione [15]. It was
found further that NO serves as a potent inhibitor of lipid
peroxidation propagation reactions [16]. The high hydro-
phobicity of NO (it is about 10 times more soluble in hexane
than in water [17]), its lipophilicity (see, e.g., Ref. [18]), its
ability to diffuse rapidly in lipophilic environments [19],
and its potent reactivity toward lipid radical species reveal
its critical role in regulating membrane and lipoprotein lipid
oxidation reactions [16].
Despite the above observations, the membrane penetra-
tion profiles of NO were largely neglected until relatively
recently. Subczynski et al. [20] sampled the profile of the
concentration-diffusion product of exogenously added NO,
at four locations in the membrane, by using spin-labeled
stearic acid analogs and electron paramagnetic resonance
(EPR) line broadening measurements [20]. Quenching of
pyrene fluorescence by NO and O2 was used to probe their
diffusion into/in the membrane by using fluorescent lipid
derivatives located at two different vertical positions in the
membrane [19]. Oxygen and nitric oxide were found to
display similar diffusional behavior, and an increased solu-
bility toward the center of the membrane.
Our aim here is to look at the penetration of NO into
lipid membranes by using the potent NO donor SNAP,
instead of exogenous NO gas. We wish to characterize the
membrane penetration of the donor, because it is expected
to release NO in membranes during in vivo applications.
The choice of SNAP as the membrane-soluble NO donor
was several fold: good thermal stability [21,22], release of
NO at manageably slow rate [23], and both biological and
therapeutic relevance (see later). The S-nitrosothiol class
of NO donors, such as SNAP [24], has many biological
activities that are related mainly to their NO storage,
transfer, and delivery functions (see Ref. [25] for a recent
review). Not only have they been suggested to generate
intermediates in signal transduction, but also the decom-
position of these compounds is of considerable biological
relevance [26]. Immediately upon solubilization, SNAP
evolves NO spontaneously by a single, irreversible, dif-
fusion-controlled reduction step [27]. SNAP is one of the
S-nitrosothiol NO donors used most for both in vivo and
in vitro studies [25,28] and, like other S-nitrosothiols, has
high therapeutic potential as an NO donor drug [23,
29,30]. The solubility of SNAP is 2 mg/ml in water
and 25 mg/ml in dimethylsulfoxide or ethanol (see, e.g.,
Bio-Stat catalogue (Stockport, GB) and Ref. [31]). Thus,
it is expected that SNAP enters into lipid membranes
[32,33], but little is known about its exact location in
membrane bilayers.
In the present paper, we use spin-label EPR to study
the localization of the SNAP NO donor in membranes of
dimyristoyl phosphatidylcholine (DMPC), and to deter-
mine the vertical profile across the membrane of NO
released from SNAP. This is done by investigating theeffects of SNAP on the mobility of the spin-labeled lipid
chains, and by measuring the enhancement of the spin-
label relaxation by paramagnetic interaction with NO. To
determine the transmembrane profiles at high vertical
resolution, we use spin-labeled positional analogs of the
host lipid that bear the nitroxide group at each position
from C4 to C14 of the phosphatidylcholine sn-2 chain.
The transmembrane profile for NO is compared with that
for oxygen, which has been investigated in some detail
recently [34]. Because there are numerous hydrophobic
targets for NO, the present results are relevant not only to
the use of SNAP-based S-nitrosothiols as NO donors, but
also to the reactivity of NO in membranes and the
consequent effects on cellular function.2. Materials and methods
2.1. Materials
DMPC was obtained from Avanti Polar Lipids (Alabas-
ter, AL). Spin-labeled phosphatidylcholines, n-PCSL (1-
acyl-2-[n-(4,4-dimethyloxazolidine-N-oxyl)stearoyl]-sn-
glycero-3-phosphocholine) with n = 4–14 were synthesized
according to Ref. [35]. The nitric oxide donor, SNAP, was
purchased from Alexis Biochemicals (Lausen, Switzerland).
Chloroform and methanol were from Merck (Darmstadt,
Germany). Oxygen and argon gas (both of 99.9% purity)
were purchased from Messer Griesheim GmbH (Frankfurt,
Germany). Double-distilled water was used in all experi-
ments and flushed with argon, except when indicated
otherwise.
2.2. Sample preparation
DMPC stock solution (10 mg/ml) was prepared in a
mixture of chloroform/methanol, 2:1 (v/v). Lipid spin
labels (n-PCSL) were prepared as stock solutions in the
same organic solvent mixture at a concentration of 1 mg/
ml. The stock solutions were kept in the freezer before use.
DMPC vesicles were labeled with n-PCSL at a mole ratio
of either 4:100 or 1:800, as follows. The desired amount of
n-PCSL (n = 4–14) stock solution was added to 100 Al of
the DMPC stock solution. After mixing, the solution was
dried under nitrogen gas flow and then under vacuum
overnight. The dry lipid film obtained was hydrated with
100 or 50 Al of water, in the high- and low-label con-
centration experiments, respectively, and loaded into a
standard 1 mm (i.d.) EPR glass capillary. According to
the particular experiment, argon or oxygen gas was flushed
into the water, both before and after hydration of the lipid
films. In some experiments, the samples were reflushed in
the capillary with argon or oxygen and the EPR spectra
were recorded again. In experiments with the NO donor,
the dry lipid films were hydrated with water (flushed with
either argon or oxygen) containing either 2 mM or a
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label/lipid = 1:800 or 4:100 mol/mol, respectively. DMPC
vesicles were pelleted in the EPR capillaries in a benchtop
centrifuge at 10000 rpm for 10 min at room temperature.
The supernatant and some lipid material was removed to
leave a uniform pellet of 5 mm length, and the capillary
was also filled with the requisite gas before being sealed
for recording EPR spectra. Flushing of argon and oxygen
into water was always done at 25 jC.
2.3. EPR spectroscopy and data analysis
EPR spectra were recorded on a Bruker (Rheinstetten,
Germany) EMX X-band (9.3 GHz) spectrometer equipped
with a TE102 cavity, using 100-kHz field modulation with a
modulation amplitude of 1 G. Samples were positioned
along the symmetry axis of the 4-mm standard quartz
sample tube, which contained light silicone oil for thermal
stability. The sample temperature was computer-controlled
by a nitrogen gas-flow temperature system that regulated the
temperature of the silicone oil. Samples were centered in the
TE102 microwave cavity. Typically four spectra, of 1024
points each, were accumulated under critical coupling con-
ditions over a 120-G scan range in 42-s scans, and digitally
averaged to reduce noise. For continuous-wave power
saturation experiments, a calibration was made between
the microwave power output and the microwave field (H1)
incident on the sample, and corrections were also made for
differences in cavity Q between different samples as de-
scribed in Ref. [36]. Spectra were recorded at microwave
powers ranging from 0.02 to 200 mW, at a temperature of
either 10, 20, or 30 jC. All processing of EPR spectra,
including determination of peak-to-peak distances, as well
as fitting, processing, and presentation of the data and CW
saturation curves, was performed using Igor (WaveMetrics,
Lake Oswego, OR) with software written by one of us
(T.P.). Integration of the spectra was done either with Igor or
with WinEPR (Bruker, Karlsruhe).3. Results and discussion
3.1. Lipid chain perturbation by SNAP
EPR spectra of positional isomers, n-PCSL, of spin-
labeled PC in DMPC membranes, at 10 and 30 jC, in the
absence and presence of SNAP, are shown in Fig. 1. In these
experiments, a label/lipid molar ratio of 4:100 was used.
This relatively high value served to detect effects of SNAP
on spin–spin interactions between the spin labels. Samples
were deoxygenated and SNAP was administered at a
saturating aqueous concentration (f 9 mM). The control
spectra show relatively broad lines in the gel phase (10 jC,
Fig. 1A), which is due partly to spin–spin interaction
between the spin labels. This effect, which dominates the
line shape at spin-label positions n = 8–12, is due to partialsegregation of the n-PCSL molecules in gel-phase DMPC,
as observed earlier with dipalmitoyl phosphatidylcholine
[37]. The presence of SNAP reduces this spin–spin inter-
action very significantly. In fluid-phase DMPC (30 jC; Fig.
1B), where spin label segregation is absent, SNAP exerts a
strong perturbing effect on the spectra that increases pro-
gressively toward positions C10–C11.
The effect of SNAP on lipid chain dynamics was
quantitated by measuring the outer hyperfine splitting of
the n-PCSL spin labels, in the absence and presence of the
NO donor. Fig. 2 shows the difference, at 10 and 30 jC, in
the outer splitting as a function of the position, n, of the
doxyl group in the acyl chain of the spin-labeled PC. In the
gel phase, SNAP has largest effect in the middle of the
bilayer and this effect shows a monotonic dependence on n.
(It should be noted that, for n = 10–12, a small contribution
to the changes observed in the outer splitting originates from
weakening the spin–spin interaction between labels by
SNAP.) In the fluid phase (30 jC), the positional depen-
dence of the chain perturbation is qualitatively similar (but
has the opposite sign), and the largest effect is detected for
positions n = 10–14.
The effect of SNAP on the spin-label segregation in the
gel phase is more evident in Fig. 3, in which spin relaxation
parameters are presented because these are more sensitive to
spin–spin interactions. Progressive (CW) saturation data
were analyzed by fitting the dependence of the spectral
second integral, I, on microwave field (H1) with the follow-




where (dI/dH1)o is the linear slope at low power, ce is the
electron gyromagnetic ratio, and T1T2 is the effective spin
relaxation time product. The latter is sensitive to spin–spin
interactions (see, e.g., Ref. [39]). Fig. 3 shows the effective
relaxation rate product 1/(T1T2) of PC spin labels in DMPC
membranes at 10 jC in the presence of SNAP for samples
preflushed with argon, relative to samples prepared in the
absence of SNAP and flushed with argon, as a function of
the spin-label position, n. The relaxation ‘‘enhancement’’ is
negative for all values of n. Because NO is known to
enhance—rather than to deenhance—spin relaxation of spin
labels in membranes [40], this confirms that the spectral
effects observed in the gel phase of DMPC at f 9 mM
aqueous SNAP are due to the donor alone and not to the
released NO. The reduction in rate of spin relaxation can be
explained by the dilution of the segregated spin label
patches by SNAP incorporated in the membrane. Conse-
quently, this negative enhancement does not follow the
perturbation profile of lipid chain mobility by SNAP (Fig.
2); it is largest where the spin-label segregation is most
pronounced, i.e., at n = 8–12, in agreement with Fig. 1A and
earlier observations [37]. The above results demonstrate that
SNAP incorporates massively in DMPC and certainly other
Fig. 1. EPR spectra of PC spin-label positional isomers, n-PCSL (as indicated for each spectrum pair) in DMPC membranes at 10 jC (panel A) and at 30 jC
(panel B) in the absence (dotted lines) and presence (solid lines) of saturating aqueous concentration (f 9 mM) of the nitric oxide donor SNAP. Spectra were
recorded at a microwave power of 5 mW and are scaled to the same maximum amplitude. The spin label/lipid molar ratio is 4:100.
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the bilayer.
3.2. Penetration of nitric oxide and oxygen into phospho-
lipid bilayers
The penetration profiles of NO and O2 into DMPC
membranes were monitored by the relaxation enhance-
ment of the n-PCSL spin labels that is induced by these
paramagnetic relaxants. The spin label/lipid molar ratio
was 1:800, and the aqueous concentration of SNAP was 2
mM. Typical CW progressive saturation curves for 4-
PCSL at 10 and 30 jC, and for 14-PCSL at 10 jC, are
shown in Fig. 4. The dependence of the integrated
intensities on the microwave field strength (H1) are
normalized to the same initial slope (dI/dH1)0 and are
fitted according to Eq. (1). Curves that saturate less
readily (e.g., 14-PCSL at 10 jC or 4-PCSL at 30 jC)
indicate faster relaxation rate products (i.e., larger 1/T1T2).
The effective spin relaxation time product (T1T2),
obtained from such CW progressive saturation experi-ments, is presented in Fig. 5 as a function of the spin-
label position, n, of the PC spin label in DMPC mem-
branes, at the different temperatures indicated. Both the
hydrating media and the samples were flushed extensively
with argon. The value of T1T2 is determined primarily by
the dynamics of the spin-label group, i.e., by the rate,
amplitude, and symmetry of its rotational diffusion. Be-
cause these dynamic features increase in intensity toward
the center of the bilayer [41,42], the T1T2 product
decreases monotonically. It also decreases with increasing
temperature. These intrinsic values serve as reference for
SNAP- and O2-treated samples. Any type of spin–spin
interaction decreases the value of T1T2 (i.e., a relaxation
enhancement). At a label/lipid molar ratio of 1:800, spin–
spin interaction between spin labels has negligible effect
on T1T2 (see, e.g., Ref. [43]).
Fig. 6 gives the relaxation enhancement parameter, R =
D(1/DHppT1T2), for NO and O2, relative to corresponding
argon-flushed samples, as a function of the spin-label
position n of the n-PCSL probes, in both gel- and fluid-
phase DMPC membranes. Oxygen was introduced into the
Fig. 2. Changes in the outer hyperfine splitting of spin-labeled PC, bearing
the doxyl group at different positions along the sn-2 acyl chain (given in the
x axis), induced by the presence of saturating aqueous concentration (f 9
mM) of the nitric oxide donor SNAP. The label/lipid ratio is 4:100, the
temperature is 10 and 30 jC for gel- and fluid-phase membranes,
respectively.
Fig. 4. CW saturation curves for double-integrated spectral intensity, as a
function of the microwave field (H1) incident on samples of PCSL spin
labels (4- and 14-PCSL) incorporated into DMPC vesicles at a label/lipid
molar ratio of 1:800, measured at the temperatures indicated. The second
integrals are scaled to the same starting slope to aid comparison. The
experimental values (symbols) were least-squares fitted according to Eq. (1)
(solid lines).
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and filling the sample capillaries before sealing them.
Control samples were flushed similarly but with argon.
Nitric oxide was released by SNAP in samples flushed with
argon. The samples were always freshly prepared and
measured as quickly as possible. Because the diffusion of
NO is fast compared with its release by SNAP [28], with theFig. 3. Changes in the effective relaxation rate product 1/T1T2 of PC spin
labels in DMPC membranes at 10 jC shown as a function of the position, n,
of the doxyl group along the hydrocarbon chain of the spin-labeled lipid
molecule. The changes show the effect of the presence of the NO donor
SNAP (f 9 mM) in samples preflushed with argon relative to samples
made in the absence of SNAP and flushed with argon. Other experimental
conditions are identical with those of Fig. 1.size of the membrane [44], and with the time scale of our
experiment, the transmembrane profile is proportional to the
local steady state concentration-diffusion product of NO
[45]. The rate of NO release from SNAP in this system,Fig. 5. Effective spin relaxation time product (T1T2) as a function of the
position of the doxyl group along the sn-2 chain of spin-labeled PC
molecules (n-PCSL) in DMPC membrane vesicles, at a molar ratio of label/
lipid = 1:800 and the temperatures indicated. Both the hydrating media and
the samples were flushed extensively with argon. The solid lines are fitted
with single exponentials for the sole purpose of comparison.
Fig. 6. Spin relaxation enhancement, R = D(1/DHppT1T2), by nitric oxide
(panel A), and by oxygen (panel B), of the positional spin label isomers
(n-PCSL) in DMPC membranes in the gel (10 jC) and fluid (30 jC)
phases. The label/lipid molar ratio was 1:800. The solid lines are least-
squares fits of Eq. (3) with parameters no = 10.2F 0.3, k= 1.4F 0.3 and
no = 7.8F 0.2, k= 0.5F 0.2 for the nitric oxide and oxygen data,
respectively.
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agents known to influence the release rate, is not known but
the shape of the CW saturation curves (Fig. 4) and the
relaxation profiles (Figs. 5 and 6) exclude the possibility of
large variations in the membranous NO concentration. This
is in agreement with the observation of an EPR signal of
spin-trapped NO released by SNAP under anaerobic con-
ditions, which was stable for several days (unpublished).
The fact that we see no relaxation enhancement in the rigid
gel phase supports the earlier observation that the spin–spin
interaction between the spin labels and the paramagnetic
gases NO and O2 is exclusively of the Heisenberg spin-
exchange type [34,40], in which the relaxant comes into
direct contact with the spin label, so that the spin orbitals







where T1,0 is the spin-lattice relaxation time in the absence of
relaxant, k0 is a constant that depends on the structure of the
interacting molecules, and DR(z) and cR(z) are the diffusion
constant and local concentration of the relaxant, respectively,
at vertical position z along the membrane normal. A similar
equation applies to T2, but because T2 is about 2 orders of
magnitude smaller than T1 for nitroxide spin labels, the
relative enhancement in 1/T2 is negligible compared with
that in 1/T1 [39]. The relaxation enhancement parameter 1/
T1T2 was therefore corrected with the peak-to-peak width
DHpp of the central line, to reduce differences between
different spin labels and to minimize the potential effect of
SNAP on the line shape [48].
The permeation of small electrolytes (metal ions) but also
nonelectrolytes (O2 and possibly NO) into the membrane is
strongly dependent on the polarity profile of the membrane
[49]. It is therefore not surprising that the permeability
profiles of NO and O2 that are shown in Fig. 6 are similar,
but are in the opposite sense, of course, to the polarity
profile of DMPC bilayers [49]. The trough-like dependences
of the relaxation enhancement, R, of NO and O2 observed at
low concentration of n-PCSL (with n = 4–14) spin labels in
fluid DMPC membranes were fitted with a sigmoidal





¼ R1  R2
1þ exp½ðn n0Þ=k þ R2 ð3Þ
where R1 and R2 are the base and maximum values of the
sigmoid, no is the point of maximum gradient, and k is the
decay constant. The fitting parameters obtained for the 30
jC data are R1= (3.3F 1.6) 1012 G 1 s 2, R2–R1= (4.0F
0.4) 1013 G 1 s 2, no = 10.2F 0.3 and k = 1.4F 0.3 for
NO; andR1=(3.4F 0.2) 1013G 1 s 2,R2–R1= (3.0F 0.3)
1013 G 1 s 2, no = 7.8F 0.2 and k = 0.5F 0.2 for O2.
These enhancements were abolished when the samples were
reflushed with argon (data not shown). Although the extents,
(R2–R1), of the NO and O2 fluid-phase profiles are compa-
rable, the profile of NO permeability appears to be shifted
down relative to that of O2 by about 3.11013 G 1 s 2. This
difference may be attributed to (i) the presence of argon in the
NO samples, which was needed to remove oxygen; (ii) the
possibly lower concentration of NO than O2 in the membrane
(in their respective samples); and (iii) the presence of the
donor in the NO samples (cf. Fig. 2). Some of the differences
also may be attributed to the difference in the polarity of NO
and O2. While O2 is nonpolar with zero dipole moment, that
for NO is 0.159 Debye [50], which also may be responsible
for the less steep profile and lower partitioning of NO
compared to O2.
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spin labels in membranes, via Heisenberg spin exchange,
was introduced for oximetry by Strzalka et al. [51] and has
been studied extensively by Hyde et al. [45,52,53]. The
same authors have also measured the permeability of nitric
oxide through lipid bilayer membranes [20]. Our profile of
relaxation enhancement is qualitatively similar to that of
Ref. [20], but is spatially better resolved. In the work by
Hyde et al. [45,52], the profile of NO was similar to that of
O2, in agreement with more limited fluorescence quenching
data [19]. In addition, cholesterol increased the maximum in
the profile of NO permeability and shifted it deeper into the
hydrophobic core of the membrane [20]. SNAP itself is
quite hydrophobic and has a molecular mass of 220 Da,
which is smaller than that of cholesterol (387 Da) but SNAP
dimerizes via S–S bridges after releasing NO [25]. There-
fore, a perturbing effect of SNAP on the NO profile can be
anticipated. It is clear from Fig. 2 that SNAP perturbs the
mobility of the lipid chains, although in a different way from
that of cholesterol. At least part of the shift and broadening
of the NO profile, relative to that for O2, may therefore be
attributed to the incorporation of the NO donor into the
hydrophobic interior of the membrane. In particular, be-
cause perturbation by the donor reaches a plateau at posi-
tions n= 10–11 in the fluid membrane, it is very likely to
influence and possibly broaden the profile of NO relative to
that of O2 for which no donor was used.
3.3. Membrane concentrations and permeability to nitric
oxide
The relaxation-rate enhancements, R =D(1/DHppT1T2),
for the nitroxides at position n that are given in Fig. 6, are
directly proportional to the product KR(n)DR(n) of the local
partition and diffusion coefficients of the relaxant in the
membrane (see Eq. (2)). Because of their comparable
molecular size, the diffusion coefficients of NO and oxygen
are likely to be similar. (In water at 20 jC, Dw = 2.35 and
2.00 10 5 cm2 s 1 for NO and O2, respectively [50].)
Comparison of the results in Figs. 6A,B therefore shows that
the steady state concentration of NO produced by SNAP in
the center of the membrane is approximately two thirds of
the equilibrium concentration of oxygen. For oxygen, it was
found that the partition-diffusion product at the interfacial
region of the membrane is K1D1c 5 10 5 cm2 s 1 [34].
From Fig. 6B, the partition-diffusion product of oxygen at
the center of the membrane then becomes K2D2 =
K1D1 (R2/R1)c 10 4 cm2 s 1 (cf. Eq. (3)). Therefore,
the partition-diffusion product for nitric oxide in the center
of the membrane is: K2D2c 7 10 5 cm2 s 1, under
steady state NO evolution by SNAP. This is the quantity
that determines the rate of reactions with NO within the
membrane. Comparison with the diffusion coefficient of NO
in water (Dw = 2.35 10 5 cm2 s 1 at 20 jC), shows that
NO reaction rates in the membrane are potentially three
times higher than those in the aqueous phase.The transmembrane profile given in Fig. 6A can be used
to determine the membrane permeability to nitric oxide.
Previous estimates have used far fewer points to define the
profile [20]. The contribution to the permeability barrier, 1/






where K(z) and D(z) are the local partition and diffusion
coefficients, respectively, for NO at distance z into the
membrane of total thickness, 2d. Using the transmembrane













where do is the distance corresponding to chain position no,
and k is also expressed as a distance. For fluid DMPC
bilayers, the width of the membrane is 2dc 3 nm with an
increment of 0.1 nm per methylene group [54]. Using the
relaxation enhancement data from above, it is found that the
hydrophobic membrane core actually enhances the NO
permeability, which is increased by a factor of 2 , relative
to that in a uniform membrane with fixed partition and
diffusion coefficients, K1 and D1. Thus, membranes can
form effective channels of communication for efficient NO
transport within cells. Taking K1D1cDw from the spin-
label linebroadening results of Subczynski et al. [20], with
Dw = 2.35 10 5 cm2 s 1 for the diffusion coefficient of
NO in water [50], yields an effective permeability coeffi-
cient P= 160 cm s 1 for NO in fluid DMPC bilayers.4. Conclusions
Direct or indirect membranous targets of NO, such as
CMC unsaturated bonds or certain amino acid side chains,
have defined vertical location in biological membranes.
Therefore, the membrane penetration profiles of NO, of its
derived reactive species, and of its potent hydrophobic
donors, are of considerable biological and biochemical
relevance. Being diffusion-controlled, most of the chemical
reactions of NO depend on the rate of collision of NO with
the target molecules or functional groups. The collision rate
between NO and its target is proportional to the concentra-
tion-diffusion product of NO, which is determined at high
vertical resolution for a phospholipid bilayer in the present
study. This allowed us to observe differences between NO
and O2 and also to locate SNAP in the membrane. In
addition, this is the first systematic study to look at the
effect of this important NO donor on a phospholipid
membrane.
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similar, chemical reactions in the membrane involving NO
or O2 will proceed at higher rates in the center of the bilayer
than in the phospholipid headgroup region. For instance,
whereas NO is protected from hydrolysis-related reactions
in the center of the membrane, products of NO autooxida-
tion are likely to be present in membranes whenever free O2
is available. As an example, the rate of NO autooxidation is
orders of magnitudes higher, if a hydrophobic lipid phase
(soy phospholipid vesicles, nonionic detergents, or mem-
branes isolated from rat hepatocytes) is present, than in an
otherwise entirely hydrophilic environment [55]. The fact
that tissues producing NO, such as liver or brain, contain a
relatively high concentration of phospholipids, combined
with the NO profile presented here, suggests that most of the
NO-dependent reactions take place in the hydrophobic core
of biomembranes. These reactions display a strong depth
dependence (see Fig. 6), which is amplified if O2-dependent
NO reactions are considered. Combined with this, the fact
that SNAP also concentrates in the hydrophobic core of the
bilayer is one of the reasons why it is an effective and
functional NO donor in in vivo experiments.
Membrane proteins that are structurally or functionally
dependent on amine, thiol, tyrosine (radical), or heme
groups, or on ternary iron complexes, are all likely to be
direct, or indirect, targets of NO [7]. The rate of reaction
between NO and such targets that are located in the
transmembrane secondary structure of integral proteins will
be proportional to the local concentration-diffusion product.
Hence, the reaction rate will show a strong dependence on
the vertical membrane location of the target residue, in
addition to depending on the extent to which the target is
exposed to the lipid phase or embedded within the protein.
This is similar to the case of oxygen, the relaxation en-
hancement by which has been used extensively to locate the
position of spin-labeled residues of membrane proteins in
the bilayer [48,56–58]. Likewise, lipid peroxidation reac-
tions should also show a strong dependence on the vertical
location of the double bonds along the acyl chain. The
present results suggest that the hydrophobic core of a fluid
membrane is one primary site of NO-dependent chemistry
in biological systems that should have a strong depen-
dence on the vertical position in the membrane. Finally,
the large difference observed between the gel- and fluid-
membrane phases suggests that NO and O2 should display
significant heterogeneity in their lateral membrane distribu-
tion, if the host biomembrane contains domains (patches,
rafts, etc.) of different composition or different lipid chain
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